Cencora falls after missing quarterly revenue estimates
** Shares of drug distributor Cencora COR.N fall 5.3% to $342.46 premarket ** Co's quarterly revenue of $85.93 billion misses analysts' average expectation of $86.03 billion ** Co reports Q1 adj. profit of $4.08/shr vs analysts' average estimate of $4.04/shr – LSEG data ** Shares were up ~50% in 2025 (Reporting by Sahil Pandey in Bengaluru) ((Sahil.Pandey@thomsonreuters.com))